Work

A Phase1/1b Dose Escalation/Dose Expansion Study of Prgn-3007 Ultracar-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies

Year: 2022
Type: article
Source: Blood
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310109057
FWCI: 0.315
Cites:
Cited by: 3
Related to: 10